Glucose-dependent acetylation of Rictor promotes targeted cancer therapy resistance
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glucose-dependent acetylation of Rictor promotes targeted cancer therapy resistance
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 112, Issue 30, Pages 9406-9411
Publisher
Proceedings of the National Academy of Sciences
Online
2015-07-14
DOI
10.1073/pnas.1511759112
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Protein kinase D1 mediates class IIa histone deacetylase phosphorylation and nuclear extrusion in intestinal epithelial cells: role in mitogenic signaling
- (2014) James Sinnett-Smith et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Acetate Is a Bioenergetic Substrate for Human Glioblastoma and Brain Metastases
- (2014) Tomoyuki Mashimo et al. CELL
- Acetate Dependence of Tumors
- (2014) Sarah A. Comerford et al. CELL
- Acetate Fuels the Cancer Engine
- (2014) Costas A. Lyssiotis et al. CELL
- Akt-Dependent Metabolic Reprogramming Regulates Tumor Cell Histone Acetylation
- (2014) Joyce V. Lee et al. Cell Metabolism
- Epigenetic Regulation of EMT: The Snail Story
- (2014) Yiwei Lin et al. CURRENT PHARMACEUTICAL DESIGN
- mTORC2 in the center of cancer metabolic reprogramming
- (2014) Kenta Masui et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Histone deacetylase inhibitors promote glioma cell death by G2 checkpoint abrogation leading to mitotic catastrophe
- (2014) M Cornago et al. Cell Death & Disease
- Metabolic complications with the use of mTOR inhibitors for cancer therapy
- (2013) Shanthi Sivendran et al. CANCER TREATMENT REVIEWS
- Cancer as a metabolic disease: implications for novel therapeutics
- (2013) T. N. Seyfried et al. CARCINOGENESIS
- Influence of Metabolism on Epigenetics and Disease
- (2013) William G. Kaelin et al. CELL
- mTOR Complex 2 Controls Glycolytic Metabolism in Glioblastoma through FoxO Acetylation and Upregulation of c-Myc
- (2013) Kenta Masui et al. Cell Metabolism
- mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy
- (2013) M. Weiler et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- mTORC1 Status Dictates Tumor Response to Targeted Therapeutics
- (2013) I. Kelsey et al. Science Signaling
- What a Tangled Web We Weave: Emerging Resistance Mechanisms to Inhibition of the Phosphoinositide 3-Kinase Pathway
- (2013) S. J. Klempner et al. Cancer Discovery
- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
- (2012) Patrick S. Ward et al. CANCER CELL
- Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us?
- (2012) Ralph J. DeBerardinis et al. CELL
- Metabolic Regulation of Epigenetics
- (2012) Chao Lu et al. Cell Metabolism
- Links between metabolism and cancer
- (2012) C. V. Dang GENES & DEVELOPMENT
- Mechanistic insights into the regulation of metabolic enzymes by acetylation
- (2012) Yue Xiong et al. JOURNAL OF CELL BIOLOGY
- ASEB: a web server for KAT-specific acetylation site prediction
- (2012) L. Wang et al. NUCLEIC ACIDS RESEARCH
- Cancer Cell Metabolism: One Hallmark, Many Faces
- (2012) Jason R. Cantor et al. Cancer Discovery
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Multiple Site Acetylation of Rictor Stimulates Mammalian Target of Rapamycin Complex 2 (mTORC2)-dependent Phosphorylation of Akt Protein
- (2011) Emily J. Glidden et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Characterization and Prediction of Lysine (K)-Acetyl-Transferase Specific Acetylation Sites
- (2011) Tingting Li et al. MOLECULAR & CELLULAR PROTEOMICS
- Acetyl-CoA Induces Cell Growth and Proliferation by Promoting the Acetylation of Histones at Growth Genes
- (2011) Ling Cai et al. MOLECULAR CELL
- Molecular pathology in adult high-grade gliomas: from molecular diagnostics to target therapies
- (2011) K. Masui et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Oncogenic EGFR Signaling Activates an mTORC2-NF- B Pathway That Promotes Chemotherapy Resistance
- (2011) K. Tanaka et al. Cancer Discovery
- Mutant EGFR is required for maintenance of glioma growth in vivo, and its ablation leads to escape from receptor dependence
- (2010) A. Mukasa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulation of Cellular Metabolism by Protein Lysine Acetylation
- (2010) S. Zhao et al. SCIENCE
- mTOR Complex 2 Is Required for the Development of Prostate Cancer Induced by Pten Loss in Mice
- (2009) David A. Guertin et al. CANCER CELL
- The molecular determinants of de novo nucleotide biosynthesis in cancer cells
- (2009) Xuemei Tong et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Association Between Hyperglycemia and Survival in Patients With Newly Diagnosed Glioblastoma
- (2009) Rachel L. Derr et al. JOURNAL OF CLINICAL ONCOLOGY
- Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
- (2009) C. Choudhary et al. SCIENCE
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- ATP-Citrate Lyase Links Cellular Metabolism to Histone Acetylation
- (2009) K. E. Wellen et al. SCIENCE
- ATP Citrate Lyase: Activation and Therapeutic Implications in Non-Small Cell Lung Cancer
- (2008) T. Migita et al. CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now